Red-Cell Aplasia, Pure - 25 Studies Found
Completed |
: A Study to Observe the Number of Patients Who Develop Pure Red Cell Aplasia (PRCA, a Rare Form of Anemia) While Receiving Epoetin Alfa or Other Recombinant Erythropoietins : Red-Cell Aplasia, Pure : 2005-09-13 |
Completed |
: A Study of Patients With Pure Red Cell Aplasia Associated With Recombinant Human Erythropoietin Treatment : Pure Red-cell Aplasia : 2005-09-13 : Other: No intervention This is an observational study. No medication will be given to the participants. |
Completed |
: Study to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Participants Receiving Epoetin Alfa or Another Erythropoietin :
: 2005-09-13 : Other: No Intervention Participants will not receive any intervention in this study. Participants with c |
Enrolling by invitation |
: Pure Red Cell Aplasia in Patients With Chronic Kidney Disease and in Use of Epoetin Alfa :
: 2016-01-05 : Procedure: Pure Red Cell Aplasia diagnostic confirmation P |
Completed |
: A Study of Risk Factors for Anti-erythropoietin Antibody Positive Pure Red Cell Aplasia Among Patients With Chronic Kidney Disease Receiving Epoetin Alfa : Pure Red-cell Aplasia : 2005-09-13 : Drug: No intervention This study is an observational study. No medication will be provided or administer |
Completed |
: Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia :
: 2006-10-20 |
Terminated |
: A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure :
: 2006-04-13 : Drug: peginesatide Other Names: |
Completed |
: Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders :
: |